# The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori

> **NCT02349685** · NA · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 219 (actual)

## Conditions studied

- Helicobacter Infection

## Interventions

- **PROCEDURE:** H. pylori culture and antimicrobial susceptibility test
- **DRUG:** 14 day PBMT group
- **DRUG:** 14 day MEA group

## Key facts

- **NCT ID:** NCT02349685
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2016-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02349685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02349685, "The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02349685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*